高级检索
周彤, 杨全良, 凌扬. 两种新药方案治疗进展期胃癌成本效益比较[J]. 实用临床医药杂志, 2006, (11): 28-29. DOI: 10.3969/j.issn.1672-2353.2006.11.009
引用本文: 周彤, 杨全良, 凌扬. 两种新药方案治疗进展期胃癌成本效益比较[J]. 实用临床医药杂志, 2006, (11): 28-29. DOI: 10.3969/j.issn.1672-2353.2006.11.009
shu
ZHOU Tong, YANG Chuan-liang, LIN Yang. A cost-benefit analysis of paclitaxel/5-fluorouracil/cisplatin compared with oxaliplatin/5-fluorouracil/leucovorin in treatment of advanced gastric cancer[J]. Journal of Clinical Medicine in Practice, 2006, (11): 28-29. DOI: 10.3969/j.issn.1672-2353.2006.11.009
Citation: ZHOU Tong, YANG Chuan-liang, LIN Yang. A cost-benefit analysis of paclitaxel/5-fluorouracil/cisplatin compared with oxaliplatin/5-fluorouracil/leucovorin in treatment of advanced gastric cancer[J]. Journal of Clinical Medicine in Practice, 2006, (11): 28-29. DOI: 10.3969/j.issn.1672-2353.2006.11.009
shu

两种新药方案治疗进展期胃癌成本效益比较

A cost-benefit analysis of paclitaxel/5-fluorouracil/cisplatin compared with oxaliplatin/5-fluorouracil/leucovorin in treatment of advanced gastric cancer

    摘要
  • 摘要: 现对本院2002年10月～2005年10月期间应用较广的TCF方案及FOLFOX 4方案治疗48例患者的疗效、不良反应、成本效益分析如下.

     

    • HTML全文
    • 参考文献(8)
    • 相关文章
    • 施引文献
  • 资源附件(0)

/

返回文章
返回